very happy to have topped up with an additional 10k at this price. Just a reminder here of the additional 5 years market exclusivity as part of Fast Track, put a number on that in the distributor negotiations!
QIDP designation was created by the Generating Antibiotic Incentives Now (GAIN) Act and provides incentives for the development of new antimicrobial products. These incentives include priority regulatory review and an additional five years’ of market exclusivity.
and if you take a look at the the current course of sales, it looks like heavy bot activity, do not get sucked into selling
- Forums
- ASX - By Stock
- Ann: VivaGel BV NDA advances to next stage of FDA review
very happy to have topped up with an additional 10k at this...
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.90M |
Open | High | Low | Value | Volume |
10.5¢ | 11.5¢ | 10.0¢ | $110.6K | 1.006M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 83046 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 30000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 83046 | 0.105 |
3 | 198569 | 0.100 |
1 | 10111 | 0.099 |
3 | 483557 | 0.096 |
1 | 824859 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 30000 | 1 |
0.115 | 122753 | 4 |
0.120 | 221197 | 6 |
0.125 | 30000 | 1 |
0.130 | 138570 | 2 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online